ACC 2015: Brilinta, PCSK9, andexanet alfa, ETC-1002 sound bites feed stock gains

Stock price gains for AstraZeneca, Amgen, Regeneron Pharmaceuticals, Portola Pharmaceuticals and Esperion Therapeutics showed that there were no biopharma losers based on data presented during the American College of Cardiology (ACC) Scientific Session & Expo despite unanswered questions about therapies in development.